Integrated Core Strategies (US) LLC

11/01/2024 | Press release | Distributed by Public on 11/01/2024 14:06

Beneficial Ownership Report - Form SC 13G

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934

ASTRIA THERAPEUTICS, INC.
(Name of Issuer)

COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)

04635X102
(CUSIP Number)

OCTOBER 28, 2024
(Date of event which requires filing of this statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

þ Rule 13d-1(c)

o Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).


CUSIP No.
04635X102

SCHEDULE 13G

Page
2
of
11

NAMES OF REPORTING PERSONS

Integrated Core Strategies (US) LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
1
5
SOLE VOTING POWER

-0-
6
SHARED VOTING POWER

2,847,554
7
SOLE DISPOSITIVE POWER

-0-
8
SHARED DISPOSITIVE POWER

2,847,554
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,847,554
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.0%
12TYPE OF REPORTING PERSON

OO
9

CUSIP No.
04635X102

SCHEDULE 13G

Page
3
of
11

NAMES OF REPORTING PERSONS

Millennium Management LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
1
5
SOLE VOTING POWER

-0-
6
SHARED VOTING POWER

2,948,876
7
SOLE DISPOSITIVE POWER

-0-
8
SHARED DISPOSITIVE POWER

2,948,876
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,948,876
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.2%
12TYPE OF REPORTING PERSON

OO
9

CUSIP No.
04635X102

SCHEDULE 13G

Page
4
of
11

NAMES OF REPORTING PERSONS

Millennium Group Management LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
1
5
SOLE VOTING POWER

-0-
6
SHARED VOTING POWER

2,948,876
7
SOLE DISPOSITIVE POWER

-0-
8
SHARED DISPOSITIVE POWER

2,948,876
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,948,876
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.2%
12TYPE OF REPORTING PERSON

OO
9

CUSIP No.
04635X102

SCHEDULE 13G

Page
5
of
11

NAMES OF REPORTING PERSONS

Israel A. Englander
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION

United States
1
5
SOLE VOTING POWER

-0-
6
SHARED VOTING POWER

2,948,876
7
SOLE DISPOSITIVE POWER

-0-
8
SHARED DISPOSITIVE POWER

2,948,876
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,948,876
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.2%
12
TYPE OF REPORTING PERSON

IN
9
CUSIP No.
04635X102

SCHEDULE 13G

Page
6
of
11
(a)Name of Issuer:Astria Therapeutics, Inc. (b)Address of Issuer's Principal Executive Offices:

22 Boston Wharf Road, 10th Floor
Boston, Massachusetts 02210

Item 2.
(a)Name of Person Filing:(b)Address of Principal Business Office:(c)Citizenship:Integrated Core Strategies (US) LLC
c/o Millennium Management LLC
399 Park Avenue
New York, New York 10022
Citizenship: DelawareMillennium Management LLC
399 Park Avenue
New York, New York 10022
Citizenship: DelawareMillennium Group Management LLC
399 Park Avenue
New York, New York 10022
Citizenship: DelawareIsrael A. Englander
c/o Millennium Management LLC
399 Park Avenue
New York, New York 10022
Citizenship: United States(d)Title of Class of Securities:common stock, par value $0.001 per share ("Common Stock")(e)CUSIP Number:0 4635X102
Item 1.

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

(a) oBroker or dealer registered under section 15 of the Act (15 U.S.C. 78o);(b) oBank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);(c) oInsurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);(d) oInvestment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);(e) oAn investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f) oAn employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
CUSIP No.
04635X102

SCHEDULE 13G

Page
7
of
11
(g) oA parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);(h) oA savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);(i)oA church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);(j) oGroup, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4. Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.(a) Amount Beneficially Owned:
See response to Item 9 on each cover page.

(b) Percent of Class:

See response to Item 11 on each cover page.

(c) Number of shares as to which such person has:

(i) Sole power to vote or to direct the vote

See response to Item 5 on each cover page.

CUSIP No.
04635X102

SCHEDULE 13G

Page
8
of
11

(ii) Shared power to vote or to direct the vote

See response to Item 6 on each cover page.

(iii) Sole power to dispose or to direct the disposition of

See response to Item 7 on each cover page.

(iv) Shared power to dispose or to direct the disposition of

See response to Item 8 on each cover page.

The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

Item 8. Identification and Classification of Members of the Group

See Exhibit I.

Item 9. Notice of Dissolution of Group

Not applicable.

Item 10. Certification

By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
CUSIP No.
04635X102

SCHEDULE 13G

Page
9
of
11

Exhibits:

Exhibit I: Joint Filing Agreement, dated as of October 31, 2024, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

CUSIP No.
04635X102

SCHEDULE 13G

Page
10
of
11

SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

Dated: October 31, 2024

By: /s/Gil Raviv

Name: Gil Raviv
Title: Global General Counsel

MILLENNIUM MANAGEMENT LLC

By: /s/Gil Raviv

Name: Gil Raviv
Title: Global General Counsel

By: /s/Gil Raviv

INTEGRATED CORE STRATEGIES (US) LLC

By: Integrated Holding Group LP,
its Managing Member

By: Millennium Management LLC,
its General Partner

MILLENNIUM GROUP MANAGEMENT LLC

Name: Gil Raviv
Title: Global General Counsel

/s/ Israel A. Englander
Israel A. Englander